Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
Notified -
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2026-05-19, 19:24
Email: info@10toptenreviews.com
10 Top Ten Reviews is part of VSG Solution JSC, an international media group and leading digital publisher.
© 2021 - 10TopTenReiews All Rights Reserved.